FORM LETTERS YOU CAN USE TO SEND TO WATSON AND SAVIENT

PLEASE FILL IN YOUR PERSONAL INFORMATION IN THESE LETTERS, SIGN THEM, FAX IT AND MAIL IT TO WATSON AND SAVIENT! THANKS


Watson's fax number is 951-493-5842
Watson's corporate office is 951-493-5300


DATE HERE

Allen Chao, PhD
Chairman and CEO
Watson Pharmaceuticals
Corporate Headquarters
311 Bonnie Circle
Corona, California 92880

Dear Dr Chao :

My name is XXXX and I am writing to ask you to reverse your decision of stopping the manufacture of nandrolone decanoate and to provide the same type of Oxandrin patient assistance program used by Savient Pharmaceuticals . I am a person living with AIDS who has used nandrolone OR OXANDRIN (OR USING IT NOW) to reverse wasting syndrome and sustain my lean body mass and quality of life. As I am sure you know, several HIV studies have shown that nandrolone and oxandrolone (Oxandrin) prevent and reverses the loss of lean body mass (LBM) that has been linked to increased risk of death in HIV while increasing strength and functional capacity. Your decision to abandon nandrolone and to sell a hight cost product such as Oxandrin without a patient assistance program affect me, my work, and thousands of people who need it to keep living a productive life.

YOUR PERSONAL STORY ABOUT WEIGHT LOSS AND HOW NANDROLONE HELPED HERE ( ONE PARAGRAH)

At an average cost of $200 a month for dose of 200 mg a week, nandrolone is a lot more cost effective and more tolerable wasting treatment than recombinant human growth hormone (Serostim) (cost: $6000 a month). You are the sole supplier of several federally-funded AIDS drug assistance and Medicaid programs that have recognized its value and have included nandrolone in their formularies to treat thousands of low income HIV-positive patients nationwide. Oxandrin, at a cost of $1100 a month, is a more expensive alternative that can also be taxing to the liver to some of us. Many people rely on patient assistance for Oxandrin and have used Savients' program to reverse their wasting syndrome.

I hope you will change your course in this matter. I will contact my congressional representative and senators to let them know about this issue that affects my health and that of thousands.

Sincerely,

**************************************************************

Mr Christopher Clement
President and CEO
Savient Pharmaceuticals, Inc.One Tower CenterFourteenth FloorEast Brunswick, New Jersey 08816


Dear Mr Clement:


I just learned that your Oxandrin patient assistance program will end soon. I am extremely outraged by your decision that will affect thousands of low income patients that live in states that do not provide Oxandrin in their drug assistance programs. Besides the exorbitantly high priced HIV–wasting drug Serostim (human growth hormone), Oxandrin is the only anabolic steroid approved specifically for the treatment of involuntary weight loss due to illness an dis key to people with HIV.

I urge you to inform the HIV patient and physician community at large about your decision and how you will ensure that patients with HIV related wasting will get treatment. Watson, the company you mention in a letter you sent to patients abandoned by your Oxandrin assistance program decided to stop selling nandrolone decanoate, a lower cost product used off-label for HIV-wasting, just as they picked up the rights for your high priced Oxandrin. I hope Savient and Watson do not become another Serono with a bad public image that will be difficult to improve after bad corporate decision making.

This is the first time in history that a company has stopped a patient assistance program for a drug in the HIV field. I am sure you do not want the media to get to know this fact and that you have thought about the right options for patients that you have decided to stop helping.

Please ensure that Watson will have an Oxandrin patient assistance program.


Sincerely,